Companies that own Valneva SE
Aramea Asset Management AG
740,000
0.95%
80,000
0.87%
09/30/2017
SK Vermögensverwaltung GmbH
650,000
0.84%
350,000
0.84%
03/31/2018
Apo Asset Management GmbH
545,513
0.7%
-35,056
0.1%
07/31/2018
Dimensional Fund Advisors LP
532,856
0.69%
12,842
0%
04/30/2018
Lupus alpha Asset Management AG
500,000
0.64%
50,000
0.13%
12/31/2017
Medical Strategy GmbH
343,457
0.44%
0
0.86%
11/30/2017
Matejka & Partner Asset Management GmbH
309,008
0.4%
60,000
0.91%
12/31/2017
WSS Vermögensmanagement GmbH
300,000
0.39%
300,000
3.26%
02/28/2018
Gestion Financière Privée SA
231,084
0.3%
0
2.34%
06/30/2017
Tocqueville Finance SA
229,451
0.3%
0
0.07%
06/29/2018
| Address |
Campus Bio-Ouest 6
Saint-Herblain Lorraine 44800
France
|
|
Employees
|
- |
| Website |
http://www.valneva.com |
| Updated |
07/08/2019 |
| Valneva SE is a biotech company which engages in the development, production, and marketing of vaccine and preventive medicine. It operates through the following segments: Commercialized Vaccines, Technologies and Services, and Vaccine Candidates. The Commercialized Vaccines segment includes currently marketed vaccines of the group such as JEV and DUKORAL. |
